Added to YB: 2025-10-03
Pitch date: 2025-10-01
IRIX [neutral]
IRIDEX Corporation
Author Info
Trident Opportunities writes about deep value and special situation investment opportunities. Sign up for the newsletter.
Company Info
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology.
Market Cap
$19.4M
Pitch Price
$1.15
Price Target
N/A
Dividend
N/A
EV/EBITDA
-10.51
P/E
-3.49
EV/Sales
0.48
Sector
Health Care Equipment and Supplies
Category
turnaround
Trident Opportunities | Portfolioupdate Q3 - 2025 - +16.7% - IRIDEX Corporation
IRIX (holding update): Medical device co w/ razor-blade model in turnaround. Q2 adj EBITDA barely positive due to probe supply issues. Author estimates would've been $0.4-0.5M positive EBITDA without supply problems. Backlog shipping resumed in Q3, expecting adj EBITDA uptick next quarter.
Read full article (1 min)